Guanhao Biotech Co

Guanhao Biotech Co EBIT per Employee

The EBIT per Employee of Guanhao Biotech Co (300238.SZ) as of Oct 31, 2026 is 50,039.25 CNY. In the previous year, EBIT per Employee was 48,197.25 CNY — a change of 3.82% (higher).

EBIT per Employee

50,039.25CNY

YoY

3.82%

Last updated:

EBIT per Employee of Guanhao Biotech Co is 2025 50,039.25 CNY. EBIT per Employee of Guanhao Biotech Co was 2024 48,197.25 CNY. It decreases by 3.82% higher compared to the previous year.

The Guanhao Biotech Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
108,884.51 CNY
Jan 1, 2019
-830,814.81 CNY
Jan 1, 2020
76,729.81 CNY
Jan 1, 2021
151,790.24 CNY
Jan 1, 2022
-490,078.57 CNY
Jan 1, 2023
58,000.96 CNY
Jan 1, 2024
48,197.25 CNY
Jan 1, 2025
50,039.25 CNY
The Guanhao Biotech Co EBIT per Employee history
YEAREBIT per EmployeeYoY
50,039.25CNY+3.82%
48,197.25CNY-16.90%
58,000.96CNY-111.84%
-490,078.57CNY-422.87%
151,790.24CNY+97.82%
76,729.81CNY-109.24%
-830,814.81CNY-863.02%
108,884.51CNY+19.94%
90,783.22CNY+12.90%
80,408.60CNY-23.60%
105,246.75CNY+20.69%
87,203.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Guanhao Biotech Co Stock analysis

What does Guanhao Biotech Co do? Guanhao Biotech Co Ltd develops and sells regenerative medical materials and implant devices, including biological dura mater patches, chest general surgery department patching membranes (type P and type B), asepsis biological wound-surface protection membranes, type B dura matrix, and intraocular lenses. The company generates revenue through the sale of these products to healthcare providers and medical institutions. Its primary customers are hospitals and surgical departments requiring advanced regenerative solutions for wound care and ophthalmic procedures. The firm also offers related technological services as part of its product portfolio. The company focuses on regenerative medical applications, targeting segments such as neurosurgery, general surgery, and ophthalmology. Its product range addresses specific clinical needs, including dura mater repair, wound protection, and vision correction. By providing specialized medical materials, Guanhao Biotech serves healthcare facilities seeking innovative solutions for patient recovery and surgical outcomes. Guanhao Biotech's core business revolves around the production and distribution of high-value medical devices and materials. The firm's revenue streams are derived from direct sales of its regenerative medical products and associated technological services. Key segments include hospitals, surgical departments, and ophthalmic clinics that utilize its specialized membranes and lenses for patient care. Guanhao Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Guanhao Biotech Co stock

EBIT per Employee of Guanhao Biotech Co is 50,039.25 CNY in 2025.

EBIT per Employee of Guanhao Biotech Co changed from 48,197.25 CNY to 50,039.25 CNY, representing a 3.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Guanhao Biotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Guanhao Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Guanhao Biotech Co

All Key Metrics — Guanhao Biotech Co